| 1 |
Nandivada P, Carlson SJ, Chang MI, et al. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions[J]. Adv Nutr, 2013, 4(6): 711-717.
|
| 2 |
Javid PJ, Greene AK, Garza J, et al. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model[J]. J Pediatr Surg, 2005, 40(9): 1446-1453.
|
| 3 |
Zaloga GP. Phytosterols, Lipid Administration, and Liver Disease During Parenteral Nutrition[J]. J Parenter Enter Nutr, 2015, 39(1): 39S-60S.
|
| 4 |
Nandivada P, Potemkin AK, Carlson S, et al. Elevated alkaline phosphatase in infants with parenteral nutrition-associated liver disease reflects bone rather than liver disease[J]. J Parenter Enter Nutr, 2014, 3(6): 311-417.
|
| 5 |
Zhu X, Zhang X, Yu L, et al. Hepatic Overexpression of GRP94 in a rabbit model of parenteral nutrition-associated liver disease[J]. Gastroenterol Res Pract, 2015, 6(13): 269831-269839.
|
| 6 |
Calkins K L, Havranek T, Kelley-Quon LI, et al. Low-dose parenteral soybean oil for the prevention of parenteral nutrition-associated liver disease in neonates with gastrointestinal disorders: a multicenter randomized controlled pilot study[J]. J Parenter Enter Nutr, 2015, 5(29): e531-e542.
|
| 7 |
Bharadwaj S, Gohel T, Deen OJ, et al. Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease[J]. Gastroenterol Rep, 2015, 3(2): 110-114.
|
| 8 |
Pastor-Clerigues A, Marti-Bonmati E, Milara J, et al. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease[J]. Plos One, 2014, 9(12): e115404.
|
| 9 |
Cober MP, Killu G, Brattain A, et al. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease[J]. J Pediatr, 2012, 160(3): 421-427.
|
| 10 |
Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management[J]. Pediatrics, 2006, 118(1): e197-e201.
|
| 11 |
Angsten G, Finkel Y, Lucas S, et al. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with omega-6/9 lipid emulsions[J]. J Parenter Enter Nutr, 2012, 36(5): 587-595.
|
| 12 |
Ng K, Stoll B, Chacko S, et al. Vitamin E in new-generation lipid emulsions protects against parenteral nutrition-associated liver disease in parenteral nutrition-fed preterm pigs[J]. J Parenter Enter Nutr, 2015, 4(5): 83-91.
|
| 13 |
Vlaardingerbroek H, Ng K, Stroll B, et al. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs[J]. J Lipid Res, 2014, 55(3): 466-477.
|
| 14 |
Turner JM, Josephson J, Field CJ, et al. Liver disease, systemic inflammation, and growth using a mixed parenteral lipid emulsion, containing soybean oil, fish oil, and medium chain triglycerides, compared with soybean oil in parenteral nutrition-fed neonatal piglets[J]. J Parenter Enter Nutr, 2015, 3(2): 110-114.
|
| 15 |
Shaw AA, Hall SD, Franklin MR, et al. The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition[J]. Drug Metab Dispos, 2002, 30(2): 177-182.
|
| 16 |
Lim DW, Wales PW, Josephson JK, et al. Glucagon-like peptide 2 improves cholestasis in parenteral nutrition-associated liver disease[J]. J Parenter Enter Nutr, 2014, 5(2): 876-882.
|
| 17 |
金未来, 夏丽乔, 马娟, 等. 熊去氧胆酸治疗早产儿静脉营养相关性胆汁淤积症疗效分析[J]. 重庆医学, 2011, 40(25): 2573-2574.
|
| 18 |
王翔, 蔡威, 洪莉, 等. 双歧杆菌减轻肠外营养幼兔肝损害的实验研究[J]. 中华小儿外科杂志, 2006, 27(3): 155-158.
|
| 19 |
Wales PW, Allen N, Worthington P, et al. A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease[J]. J Parenter Enter Nutr, 2014, 38(5): 538-557.
|